CHIP Clinic's goals: Research, preventive care
The effect of mefloquine on acute leukemia cell lines
First agent in a new class of noncytotoxic cancer drugs
Collaborative, personalized approach optimizes patient outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study shows risk of overtreating patients
Precision therapy for refractory disease now FDA approved
Advertisement
Advertisement